High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor

Abstract Background Non-muscle-invasive bladder cancer (NMIBC) is treated with transurethral resection of bladder tumor (TURBT) followed by intravesical instillation of chemotherapy or Bacillus Calmette–Guérin therapy. However, these treatments have a high recurrence rate and side effects, emphasizi...

Full description

Bibliographic Details
Main Authors: Fangming Wang, Gang Zhang, Tianli Xu, Jianlin Ma, Jing Wang, Shuai Liu, Yuzhe Tang, Song Jin, Jianxing Li, Nianzeng Xing
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:https://doi.org/10.1186/s13046-024-02955-7
_version_ 1797349682048925696
author Fangming Wang
Gang Zhang
Tianli Xu
Jianlin Ma
Jing Wang
Shuai Liu
Yuzhe Tang
Song Jin
Jianxing Li
Nianzeng Xing
author_facet Fangming Wang
Gang Zhang
Tianli Xu
Jianlin Ma
Jing Wang
Shuai Liu
Yuzhe Tang
Song Jin
Jianxing Li
Nianzeng Xing
author_sort Fangming Wang
collection DOAJ
description Abstract Background Non-muscle-invasive bladder cancer (NMIBC) is treated with transurethral resection of bladder tumor (TURBT) followed by intravesical instillation of chemotherapy or Bacillus Calmette–Guérin therapy. However, these treatments have a high recurrence rate and side effects, emphasizing the need for alternative instillations. Previously, we revealed that expanded allogeneic human natural killer (NK) cells from peripheral blood are a promising cellular therapy for prostate cancer. However, whether NK cells exhibit a similar killing effect in bladder cancer (BCa) remains unknown. Methods Expansion, activation, and cryopreservation of allogeneic human NK cells obtained from peripheral blood were performed as we previously described. In vitro cytotoxicity was evaluated using the cell counting kit-8. The levels of perforin, granzyme B, interferon-γ, tumor necrosis factor-α, and chemokines (C-C-motif ligand [CCL]1, CCL2, CCL20, CCL3L1, and CCL4; C-X-C-motif ligand [CXCL]1, CXCL16, CXCL2, CXCL3, and CXCL8; and X-motif ligand 1 and 2) were determined using enzyme-linked immunosorbent assay. The expression of CD107a, major histocompatibility complex class I (MHC-I), MHC-I polypeptide-related sequences A and B (MICA/B), cytomegalovirus UL16-binding protein-2/5/6 (ULBP-2/5/6), B7-H6, CD56, CD69, CD25, killer cell Ig-like receptors (KIR)2DL1, KIRD3DL1, NKG2D, NKp30, NKp46, and CD16 of NK cells or BCa and normal urothelial cells were detected using flow cytometry. Cytotoxicity was evaluated using lactate dehydrogenase assay in patient-derived organoid models. BCa growth was monitored in vivo using calipers in male NOD-scid IL2rg−/− mice subcutaneously injected with 5637 and NK cells. Differential gene expressions were investigated using RNA sequence analysis. The chemotaxis of T cells was evaluated using transwell migration assays. Results We revealed that the NK cells possess higher cytotoxicity against BCa lines with more production of cytokines than normal urothelial cells counterparts in vitro, demonstrated by upregulation of degranulation marker CD107a and increased interferon-γ secretion, by MICA/B/NKG2D and B7H6/NKp30-mediated activation. Furthermore, NK cells demonstrated antitumor effects against BCa in patient-derived organoids and BCa xenograft mouse models. NK cells secreted chemokines, including CCL1/2/20, to induce T-cell chemotaxis when encountering BCa cells. Conclusions The expanded NK cells exhibit potent cytotoxicity against BCa cells, with few toxic side effects on normal urothelial cells. In addition, NK cells recruit T cells by secreting a panel of chemokines, which supports the translational application of NK cell intravesical instillation after TURBT from bench to bedside for NMIBC treatment.
first_indexed 2024-03-08T12:33:55Z
format Article
id doaj.art-e4f3e864202040dfa8c38512735bcf7e
institution Directory Open Access Journal
issn 1756-9966
language English
last_indexed 2024-03-08T12:33:55Z
publishDate 2024-01-01
publisher BMC
record_format Article
series Journal of Experimental & Clinical Cancer Research
spelling doaj.art-e4f3e864202040dfa8c38512735bcf7e2024-01-21T12:39:44ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662024-01-0143111910.1186/s13046-024-02955-7High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumorFangming Wang0Gang Zhang1Tianli Xu2Jianlin Ma3Jing Wang4Shuai Liu5Yuzhe Tang6Song Jin7Jianxing Li8Nianzeng Xing9Department of Urology, Tsinghua University Affiliated Beijing Tsinghua Changgung Hospital, Tsinghua University Clinical InstituteDepartment of Urology, Tsinghua University Affiliated Beijing Tsinghua Changgung Hospital, Tsinghua University Clinical InstituteBOE Regenerative Medicine Technology Co. LtdBOE Regenerative Medicine Technology Co. LtdBOE Regenerative Medicine Technology Co. LtdBOE Regenerative Medicine Technology Co. LtdDepartment of Urology, Tsinghua University Affiliated Beijing Tsinghua Changgung Hospital, Tsinghua University Clinical InstituteDepartment of Urology, Tsinghua University Affiliated Beijing Tsinghua Changgung Hospital, Tsinghua University Clinical InstituteDepartment of Urology, Tsinghua University Affiliated Beijing Tsinghua Changgung Hospital, Tsinghua University Clinical InstituteDepartment of Urology, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical CollegeAbstract Background Non-muscle-invasive bladder cancer (NMIBC) is treated with transurethral resection of bladder tumor (TURBT) followed by intravesical instillation of chemotherapy or Bacillus Calmette–Guérin therapy. However, these treatments have a high recurrence rate and side effects, emphasizing the need for alternative instillations. Previously, we revealed that expanded allogeneic human natural killer (NK) cells from peripheral blood are a promising cellular therapy for prostate cancer. However, whether NK cells exhibit a similar killing effect in bladder cancer (BCa) remains unknown. Methods Expansion, activation, and cryopreservation of allogeneic human NK cells obtained from peripheral blood were performed as we previously described. In vitro cytotoxicity was evaluated using the cell counting kit-8. The levels of perforin, granzyme B, interferon-γ, tumor necrosis factor-α, and chemokines (C-C-motif ligand [CCL]1, CCL2, CCL20, CCL3L1, and CCL4; C-X-C-motif ligand [CXCL]1, CXCL16, CXCL2, CXCL3, and CXCL8; and X-motif ligand 1 and 2) were determined using enzyme-linked immunosorbent assay. The expression of CD107a, major histocompatibility complex class I (MHC-I), MHC-I polypeptide-related sequences A and B (MICA/B), cytomegalovirus UL16-binding protein-2/5/6 (ULBP-2/5/6), B7-H6, CD56, CD69, CD25, killer cell Ig-like receptors (KIR)2DL1, KIRD3DL1, NKG2D, NKp30, NKp46, and CD16 of NK cells or BCa and normal urothelial cells were detected using flow cytometry. Cytotoxicity was evaluated using lactate dehydrogenase assay in patient-derived organoid models. BCa growth was monitored in vivo using calipers in male NOD-scid IL2rg−/− mice subcutaneously injected with 5637 and NK cells. Differential gene expressions were investigated using RNA sequence analysis. The chemotaxis of T cells was evaluated using transwell migration assays. Results We revealed that the NK cells possess higher cytotoxicity against BCa lines with more production of cytokines than normal urothelial cells counterparts in vitro, demonstrated by upregulation of degranulation marker CD107a and increased interferon-γ secretion, by MICA/B/NKG2D and B7H6/NKp30-mediated activation. Furthermore, NK cells demonstrated antitumor effects against BCa in patient-derived organoids and BCa xenograft mouse models. NK cells secreted chemokines, including CCL1/2/20, to induce T-cell chemotaxis when encountering BCa cells. Conclusions The expanded NK cells exhibit potent cytotoxicity against BCa cells, with few toxic side effects on normal urothelial cells. In addition, NK cells recruit T cells by secreting a panel of chemokines, which supports the translational application of NK cell intravesical instillation after TURBT from bench to bedside for NMIBC treatment.https://doi.org/10.1186/s13046-024-02955-7Non-muscle-invasive bladder cancerNatural killer cellsTransurethral resection of bladder tumorIntravesical instillationChemokine
spellingShingle Fangming Wang
Gang Zhang
Tianli Xu
Jianlin Ma
Jing Wang
Shuai Liu
Yuzhe Tang
Song Jin
Jianxing Li
Nianzeng Xing
High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor
Journal of Experimental & Clinical Cancer Research
Non-muscle-invasive bladder cancer
Natural killer cells
Transurethral resection of bladder tumor
Intravesical instillation
Chemokine
title High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor
title_full High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor
title_fullStr High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor
title_full_unstemmed High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor
title_short High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor
title_sort high and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer implications for natural killer cell instillation after transurethral resection of bladder tumor
topic Non-muscle-invasive bladder cancer
Natural killer cells
Transurethral resection of bladder tumor
Intravesical instillation
Chemokine
url https://doi.org/10.1186/s13046-024-02955-7
work_keys_str_mv AT fangmingwang highandselectivecytotoxicityofexvivoexpandedallogeneichumannaturalkillercellsfromperipheralbloodagainstbladdercancerimplicationsfornaturalkillercellinstillationaftertransurethralresectionofbladdertumor
AT gangzhang highandselectivecytotoxicityofexvivoexpandedallogeneichumannaturalkillercellsfromperipheralbloodagainstbladdercancerimplicationsfornaturalkillercellinstillationaftertransurethralresectionofbladdertumor
AT tianlixu highandselectivecytotoxicityofexvivoexpandedallogeneichumannaturalkillercellsfromperipheralbloodagainstbladdercancerimplicationsfornaturalkillercellinstillationaftertransurethralresectionofbladdertumor
AT jianlinma highandselectivecytotoxicityofexvivoexpandedallogeneichumannaturalkillercellsfromperipheralbloodagainstbladdercancerimplicationsfornaturalkillercellinstillationaftertransurethralresectionofbladdertumor
AT jingwang highandselectivecytotoxicityofexvivoexpandedallogeneichumannaturalkillercellsfromperipheralbloodagainstbladdercancerimplicationsfornaturalkillercellinstillationaftertransurethralresectionofbladdertumor
AT shuailiu highandselectivecytotoxicityofexvivoexpandedallogeneichumannaturalkillercellsfromperipheralbloodagainstbladdercancerimplicationsfornaturalkillercellinstillationaftertransurethralresectionofbladdertumor
AT yuzhetang highandselectivecytotoxicityofexvivoexpandedallogeneichumannaturalkillercellsfromperipheralbloodagainstbladdercancerimplicationsfornaturalkillercellinstillationaftertransurethralresectionofbladdertumor
AT songjin highandselectivecytotoxicityofexvivoexpandedallogeneichumannaturalkillercellsfromperipheralbloodagainstbladdercancerimplicationsfornaturalkillercellinstillationaftertransurethralresectionofbladdertumor
AT jianxingli highandselectivecytotoxicityofexvivoexpandedallogeneichumannaturalkillercellsfromperipheralbloodagainstbladdercancerimplicationsfornaturalkillercellinstillationaftertransurethralresectionofbladdertumor
AT nianzengxing highandselectivecytotoxicityofexvivoexpandedallogeneichumannaturalkillercellsfromperipheralbloodagainstbladdercancerimplicationsfornaturalkillercellinstillationaftertransurethralresectionofbladdertumor